120 related articles for article (PubMed ID: 4544039)
1. [Studies on column fractionation of immune cells. 3. Tumor neutralization test].
Eckert R; Pasternak G
Acta Biol Med Ger; 1973; 31(2):305-10. PubMed ID: 4544039
[No Abstract] [Full Text] [Related]
2. Immunologic response of AKR mice in different phases of development of transplanted gross leukemia. II. Comparative investigation of cellular and humoral antibody formation.
Golubska B; Szalaty H; Stelmachowska A; Skurska Z
Arch Immunol Ther Exp (Warsz); 1971; 19(3):369-76. PubMed ID: 4938012
[No Abstract] [Full Text] [Related]
3. [Mouse rosette forming cells in transplantation immunity].
Brondz BD; Eliseeva LS; Kotomina IF; Egorova SG
Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
[No Abstract] [Full Text] [Related]
4. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
Mortensen RF
J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
[No Abstract] [Full Text] [Related]
5. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
Leclerc JC; Cantor H
J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332
[TBL] [Abstract][Full Text] [Related]
6. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
Merino F
Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
[No Abstract] [Full Text] [Related]
7. [Humoral immunity in viral reticulosarcomatosis in mice].
Bergol'ts VM; Moskovkina OIa; Sokolov PP; Sukhin GM; Kondrat'eva IA
Vopr Onkol; 1974; 20(11):35-9. PubMed ID: 4373907
[No Abstract] [Full Text] [Related]
8. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
Plata F; Gomard E; Leclerc JC; Levy JP
J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
[No Abstract] [Full Text] [Related]
9. Cellular immunoadsorbents: a simplified technique for separation of lymphoid cell populations.
Kedar E; Ortiz de Landazuri M; Bonavida B
J Immunol; 1974 Mar; 112(3):1231-43. PubMed ID: 4590702
[No Abstract] [Full Text] [Related]
10. Studies on immunity to mouse sarcomas using the tumor-cell neutralization test.
Thomas HC; Hellström KE; Kall MA; Hellström I; Van Belle G
Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(2):291-301. PubMed ID: 898502
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic characterization of sarcomas artificially infected with Graffi leukemia virus. II. Studies on the differentiation between viral and new cellular antigens].
Pasternak L; Pasternak G
Arch Geschwulstforsch; 1968; 32(4):301-8. PubMed ID: 4308111
[No Abstract] [Full Text] [Related]
12. Embryonic antigens in tumor immunity.
Della Porta G
Johns Hopkins Med J Suppl; 1974; 3():279-87. PubMed ID: 4138923
[No Abstract] [Full Text] [Related]
13. Immune responses to virus induced experimental leukemia and to human leukemia.
Herberman RB
Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
[No Abstract] [Full Text] [Related]
14. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
15. [Antigenic systems of tumors and leukemias induced by oncornaviruses].
Levy JP; Kourilsky FM
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):741-53. PubMed ID: 4340545
[No Abstract] [Full Text] [Related]
16. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
Martin WJ; Wunderlich JR; Macdonald J
Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
[No Abstract] [Full Text] [Related]
17. Immune response of mice to concanavalin A-coated EL 4 leukemia.
Martin WJ; Wunderlich JR
Natl Cancer Inst Monogr; 1972 Dec; 35():295-9. PubMed ID: 4679048
[No Abstract] [Full Text] [Related]
18. Proceedings: Proposed mechanisms by which autochthonous neoplasms escape immune rejection.
Coggin JH; Ambrose KR; Dierlam PJ; Anderson NG
Cancer Res; 1974 Aug; 34(8):2092-101. PubMed ID: 4366506
[No Abstract] [Full Text] [Related]
19. T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.
Leclerc JC; Cantor H
J Immunol; 1980 Feb; 124(2):851-4. PubMed ID: 6243333
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
